GSK to 'drop patents in poor countries'

BBC News

Pharmaceutical firm GlaxoSmithKline has said it wants to make it easier for manufacturers in the world's poorest countries to copy its medicines. The British company said it would not file patents in these countries. Chief executive Sir Andrew Witty said he wanted to take a "graduated" approach to the company's "intellectual property" based on the wealth of nations around the globe. Experts have described the plans as "brave and positive". GSK hopes that by removing any fear of it filing for patent protection in poorer countries it will allow independent companies to make and sell versions of its drugs in those areas, thereby widening the public access to them.

AstraZeneca Revenue Down as Key Drugs Lose Patent Protection

U.S. News

Anglo-Swedish drugmaker AstraZeneca says second-quarter revenue fell amid declining sales of blockbuster drugs Crestor and Seroquel XR, which lost patent protection in the United States last year.

Major China company, Alibaba, joins Open Invention Network patent protection group


The American and Chinese trade war is near to boiling. The American attempt to extradite Huawei CFO Meng Wanzhou has failed; China might be behind the Marriott data breach; and China might've caused a massive internet disruption. But one perpetual sore point between the US and China -- intellectual property (IP) abuse -- is taking a step for the better. Alibaba and its affiliate Ant Financial are joining the Open Invention Network (OIN), the pro-open source and Linux patent-protection group. Alibaba -- think of it as China's Amazon and eBay -- has a net worth of over $80 billion dollars.

Affordable Patent Applications Free Consultations 800-528-1997


IDP Patent Services is a leading provider of high-quality affordable patent application services. Call us today at 800-528-1997 for a free consultation! We work with patent application clients US nationwide, as well as with international clients seeking patent protection in the United States. We also offer international patenting, including PCT patent applications. Most services are provided on a fixed fee or capped fee basis in order to provide cost-efficient patent and IP protection for our clients.

AI in patent law: Enabler or hindrance?


Filing a patent is the clerical equivalent of pulling teeth -- at least in the U.S. It first requires inventors to determine the type of intellectual property (IP) protection they require (i.e., utility, design, or plant). Then they're on the hook to conduct a United States Patent and Trademark Office (USPTO) database search for similar inventions. If and only if the novelty of their idea passes muster are they allowed to proceed to the next step, which is preparing an application and fees. The system has motivated people like former aerospace engineer Dr. Stephen Thaler to turn to AI in pursuit of a better way. He, along with a team of legal experts and engineers, developed DABUS, a "creativity machine" that's able to generate ideas without human intervention.